What is the dose strength of guaifenesin-dextromethorphan (DM) taken twice daily for 10 days?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Guaifenesin-Dextromethorphan Dosing

The standard dose strength for guaifenesin-dextromethorphan (DM) taken twice daily is guaifenesin 200 mg/dextromethorphan 20 mg per 10 mL, administered as 10 mL (one unit dose cup) twice daily for 10 days. 1

FDA-Approved Formulations

The FDA-approved formulation provides two concentration options 1:

  • 5 mL formulation: Guaifenesin 100 mg + Dextromethorphan 10 mg per 5 mL
  • 10 mL formulation: Guaifenesin 200 mg + Dextromethorphan 20 mg per 10 mL

For BID (twice daily) dosing over 10 days, the 10 mL unit dose cup is the standard preparation, delivering 200 mg guaifenesin and 20 mg dextromethorphan per dose 1.

Clinical Context and Evidence Limitations

Important Caveats About This Combination

While this combination is widely available and FDA-approved, the evidence supporting its efficacy is mixed:

  • Dextromethorphan: Studies show variable results. Some trials demonstrated 19-50% reduction in cough counts at 30-60 mg doses 2, while others showed no significant difference from placebo in cough frequency or severity 2. The 20 mg dose in this formulation is below the 30 mg threshold where some studies showed benefit.

  • Guaifenesin: Recent evidence questions its expectorant efficacy, with studies showing no significant benefits over placebo for upper respiratory disease 3. A 1993 trial found guaifenesin alone equally effective as guaifenesin plus codeine or dextromethorphan, suggesting minimal additive benefit 4.

Guideline Perspective

The 2006 CHEST guidelines specifically state: "over the counter combination cold medications, with the exception of an older antihistamine-decongestant, are not recommended until randomized controlled trials prove that they are effective cough suppressants" 2. This recommendation carries a Grade D (benefit: none) rating.

Practical Dosing Algorithm

If prescribing this combination despite limited evidence:

  • Administer 10 mL (200 mg/20 mg) twice daily
  • Maximum duration: 10 days as specified
  • Take with or without food
  • Ensure adequate hydration

Consider alternatives given the weak evidence base, particularly for chronic or unexplained cough where multimodality speech pathology therapy (Grade 2C) or neuromodulators like gabapentin show stronger evidence 5.

References

Research

Guaifenesin: The Ubiquitous Orphan.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2024

Research

Clinical trial examining effectiveness of three cough syrups.

The Journal of the American Board of Family Practice, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.